• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杜氏肌营养不良症(DMD)的肌病轨迹显示,卫星细胞衰老导致缺乏再生。

Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells.

机构信息

Univ Paris Est Creteil, INSERM, IMRB, 94010, Creteil, France.

Centre of Translational and Experimental Myology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

出版信息

Acta Neuropathol Commun. 2023 Oct 19;11(1):167. doi: 10.1186/s40478-023-01657-z.

DOI:10.1186/s40478-023-01657-z
PMID:37858263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10585739/
Abstract

Duchenne muscular dystrophy (DMD) is a devastating X-linked muscular disease, caused by mutations in the DMD gene encoding Dystrophin and affecting 1:5000 boys worldwide. Lack of Dystrophin leads to progressive muscle wasting and degeneration resulting in cardiorespiratory failure. Despite the absence of a definitive cure, innovative therapeutic avenues are emerging. Myopathologic studies are important to further understand the biological mechanisms of the disease and to identify histopathologic benchmarks for clinical evaluations. We conducted a myopathologic analysis on twenty-four muscle biopsies from DMD patients, with particular emphasis on regeneration, fibro-adipogenic progenitors and muscle stem cells behavior. We describe an increase in content of fibro-adipogenic progenitors, central orchestrators of fibrotic progression and lipid deposition, concurrently with a decline in muscle regenerative capacity. This regenerative impairment strongly correlates with compromised activation and expansion of muscle stem cells. Furthermore, our study uncovers an early acquisition of a senescence phenotype by DMD-afflicted muscle stem cells. Here we describe the myopathologic trajectory intrinsic to DMD and establish muscle stem cell senescence as a pivotal readout for future therapeutic interventions.

摘要

杜氏肌营养不良症(DMD)是一种破坏性的 X 连锁肌肉疾病,由编码肌营养不良蛋白的 DMD 基因突变引起,影响全球每 5000 名男孩中的 1 名。缺乏肌营养不良蛋白会导致肌肉进行性消瘦和退化,从而导致心肺衰竭。尽管没有明确的治愈方法,但新的治疗途径正在出现。肌病理研究对于进一步了解疾病的生物学机制以及确定临床评估的组织病理学基准非常重要。我们对 24 例 DMD 患者的肌肉活检进行了肌病理分析,特别强调了再生、纤维脂肪祖细胞和肌肉干细胞行为。我们描述了纤维脂肪祖细胞含量的增加,纤维发生进展和脂质沉积的中枢协调者,同时肌肉再生能力下降。这种再生损伤与肌肉干细胞激活和扩增受损强烈相关。此外,我们的研究揭示了 DMD 受累肌肉干细胞早期获得衰老表型。在这里,我们描述了 DMD 内在的肌病理轨迹,并确立了肌肉干细胞衰老作为未来治疗干预的关键指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed44/10585739/ec45c915017b/40478_2023_1657_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed44/10585739/c0fb80577826/40478_2023_1657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed44/10585739/535d8e8f790c/40478_2023_1657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed44/10585739/ec45c915017b/40478_2023_1657_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed44/10585739/c0fb80577826/40478_2023_1657_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed44/10585739/535d8e8f790c/40478_2023_1657_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed44/10585739/ec45c915017b/40478_2023_1657_Fig3_HTML.jpg

相似文献

1
Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells.杜氏肌营养不良症(DMD)的肌病轨迹显示,卫星细胞衰老导致缺乏再生。
Acta Neuropathol Commun. 2023 Oct 19;11(1):167. doi: 10.1186/s40478-023-01657-z.
2
Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy.细胞衰老介导的杜氏肌营养不良症恶化。
Sci Rep. 2020 Oct 12;10(1):16385. doi: 10.1038/s41598-020-73315-6.
3
Empowering Muscle Stem Cells for the Treatment of Duchenne Muscular Dystrophy.增强肌肉干细胞用于治疗杜氏肌营养不良症
Cells Tissues Organs. 2022;211(6):641-654. doi: 10.1159/000514305. Epub 2021 Apr 28.
4
Satellite Cells in Muscular Dystrophy - Lost in Polarity.肌营养不良中的卫星细胞——极性丧失
Trends Mol Med. 2016 Jun;22(6):479-496. doi: 10.1016/j.molmed.2016.04.002. Epub 2016 May 5.
5
Targeting fibrosis in Duchenne muscular dystrophy.靶向治疗杜氏肌营养不良症的纤维化。
J Neuropathol Exp Neurol. 2010 Aug;69(8):771-6. doi: 10.1097/NEN.0b013e3181e9a34b.
6
The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.X 连锁的贝克型肌营养不良症(bmx)小鼠通过删除肌营养不良蛋白外显子 45-47 来模拟贝克型肌营养不良症。
J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):940-954. doi: 10.1002/jcsm.13171. Epub 2023 Jan 11.
7
Partial Ablation of Non-Myogenic Progenitor Cells as a Therapeutic Approach to Duchenne Muscular Dystrophy.非肌源性祖细胞部分消融作为杜氏肌营养不良症的一种治疗方法。
Biomolecules. 2021 Oct 15;11(10):1519. doi: 10.3390/biom11101519.
8
RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy.RhoA/ROCK2 信号在成纤维脂肪祖细胞中被 PDGF-AA 增强:对杜氏肌营养不良症的影响。
J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):1373-1384. doi: 10.1002/jcsm.12923. Epub 2022 Feb 7.
9
Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy.肌肉再生和杜氏肌营养不良症进展中的表观遗传修饰。
Clin Epigenetics. 2021 Jan 19;13(1):13. doi: 10.1186/s13148-021-01001-z.
10
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.mdx和dko营养不良小鼠以及杜氏肌营养不良症患者骨骼肌中Notch信号通路的改变。
Exp Physiol. 2014 Apr;99(4):675-87. doi: 10.1113/expphysiol.2013.077255. Epub 2014 Jan 17.

引用本文的文献

1
AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects.腺相关病毒微小肌营养不良蛋白基因替代疗法治疗杜氏肌营养不良症:进展与前景
Gene Ther. 2025 Aug 15. doi: 10.1038/s41434-025-00561-6.
2
Bioactive lipid mediator class switching regulates myogenic cell progression and muscle regeneration.生物活性脂质介质类别转换调节成肌细胞进程和肌肉再生。
Nat Commun. 2025 Jul 1;16(1):5578. doi: 10.1038/s41467-025-60586-8.
3
Muscle stem cells in Duchenne muscular dystrophy exhibit molecular impairments and altered cell fate trajectories impacting regenerative capacity.

本文引用的文献

1
Thyroid-stimulating hormone receptor signaling restores skeletal muscle stem cell regeneration in rats with muscular dystrophy.促甲状腺激素受体信号转导恢复肌营养不良症大鼠骨骼肌干细胞的再生。
Sci Transl Med. 2023 Mar;15(685):eadd5275. doi: 10.1126/scitranslmed.add5275. Epub 2023 Mar 1.
2
Disease progression rates in ambulatory Duchenne muscular dystrophy by steroid type, patient age and functional status.依类固醇类型、患者年龄和功能状态划分的门诊型杜氏肌营养不良症的疾病进展率。
J Comp Eff Res. 2023 Apr;12(4):e220190. doi: 10.57264/cer-2022-0190. Epub 2023 Feb 7.
3
Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration.
杜兴氏肌肉营养不良症中的肌肉干细胞表现出分子损伤以及影响再生能力的细胞命运轨迹改变。
Cell Death Dis. 2025 Jun 5;16(1):437. doi: 10.1038/s41419-025-07755-1.
4
Forskolin treatment enhances muscle regeneration and shows therapeutic potential with limitations in Duchenne muscular dystrophy.福司可林治疗可增强肌肉再生,并在杜氏肌营养不良症中显示出有局限性的治疗潜力。
Skelet Muscle. 2025 May 7;15(1):12. doi: 10.1186/s13395-025-00381-7.
5
Anti-fibrotic, muscle-promoting antibody-drug conjugates for the improvement and treatment of DMD.用于改善和治疗杜氏肌营养不良症的抗纤维化、促进肌肉生长的抗体药物偶联物。
iScience. 2025 Apr 2;28(5):112335. doi: 10.1016/j.isci.2025.112335. eCollection 2025 May 16.
6
Strategy for drug repurposing in fibroadipogenic replacement during muscle wasting: application to duchenne muscular dystrophy.肌肉萎缩过程中纤维脂肪生成替代的药物重新利用策略:应用于杜氏肌营养不良症
Front Cell Dev Biol. 2025 Mar 26;13:1505697. doi: 10.3389/fcell.2025.1505697. eCollection 2025.
7
Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy.杜氏肌营养不良反义寡核苷酸介导的外显子跳跃疗法的进展与前景
J Muscle Res Cell Motil. 2025 Jan 30. doi: 10.1007/s10974-024-09688-2.
8
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target.1型强直性肌营养不良的新视野:细胞衰老作为治疗靶点
Bioessays. 2025 Mar;47(3):e202400216. doi: 10.1002/bies.202400216. Epub 2024 Dec 26.
9
Myofibers cultured in viscoelastic hydrogels reveal the effects of integrin-binding and mechanosensing on muscle satellite cells.在粘弹性水凝胶中培养的肌纤维揭示了整合素结合和机械传感对肌肉卫星细胞的影响。
Acta Biomater. 2025 Jan 15;192:48-60. doi: 10.1016/j.actbio.2024.11.044. Epub 2024 Nov 28.
10
Cell transplantation-mediated dystrophin supplementation efficacy in Duchenne muscular dystrophy mouse motor function improvement demonstrated by enhanced skeletal muscle fatigue tolerance.细胞移植介导的肌营养不良蛋白补充在杜氏肌营养不良症小鼠运动功能改善中的功效表现为增强骨骼肌疲劳耐受性。
Stem Cell Res Ther. 2024 Sep 19;15(1):313. doi: 10.1186/s13287-024-03922-x.
衰老图谱揭示了一种衰老样炎症微环境,削弱了肌肉再生。
Nature. 2023 Jan;613(7942):169-178. doi: 10.1038/s41586-022-05535-x. Epub 2022 Dec 21.
4
Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination.氨甲酰磷酸合成酶 1,鸟氨酸转移酶 1 缺乏症
Nat Commun. 2022 May 6;13(1):2413. doi: 10.1038/s41467-022-30080-6.
5
Duchenne muscular dystrophy trajectory in R-DMDdel52 preclinical rat model identifies COMP as biomarker of fibrosis.Duchenne 肌营养不良症在 R-DMDdel52 临床前大鼠模型中的轨迹将 COMP 鉴定为纤维化的生物标志物。
Acta Neuropathol Commun. 2022 Apr 25;10(1):60. doi: 10.1186/s40478-022-01355-2.
6
Cellular Senescence: Molecular Targets, Biomarkers, and Senolytic Drugs.细胞衰老:分子靶点、生物标志物和衰老细胞选择性清除药物。
Int J Mol Sci. 2022 Apr 10;23(8):4168. doi: 10.3390/ijms23084168.
7
A dog model for centronuclear myopathy carrying the most common DNM2 mutation.携带最常见 DNM2 突变的中央核肌病犬模型。
Dis Model Mech. 2022 Apr 1;15(4). doi: 10.1242/dmm.049219. Epub 2022 Apr 14.
8
Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients.依伐布雷定改善射血分数降低心衰患者运动耐量及生活质量
J Comp Eff Res. 2022 Feb;11(3):139-155. doi: 10.2217/cer-2021-0196. Epub 2021 Nov 18.
9
Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy.关于无义突变型杜氏肌营养不良症患者使用地夫可特与泼尼松/强的松治疗的荟萃分析。
J Comp Eff Res. 2021 Dec;10(18):1337-1347. doi: 10.2217/cer-2021-0018. Epub 2021 Oct 25.
10
Life Expectancy in Duchenne Muscular Dystrophy: Reproduced Individual Patient Data Meta-analysis.杜氏肌营养不良症患者的预期寿命:再现的个体患者数据荟萃分析。
Neurology. 2021 Dec 7;97(23):e2304-e2314. doi: 10.1212/WNL.0000000000012910. Epub 2021 Oct 13.